Research at IGP
Research at IGP is basic, translational and clinical and there is a close collaboration between pre-clinical and clinical scientists.
Our research aims to increase biological understanding of development and disease, and improve diagnostics and treatment. The overarching goal is translational medicine, i.e. to link basic research with clinical applications, in disease areas such as cancer, autoimmunity, degenerative and genetic diseases.
The Department’s research groups are divided into nine research programmes:
Clinical and Experimental Pathology
Experimental and Clinical Oncology
Human Protein Atlas
Medical Genetics and Genomics
Medical Radiation Sciences
Here you can find a list of research group leaders
Research at the Department is also described in IGP's information brochure (pdf)
New research findings
- Beta blockers can repair malformed blood vessels in the brain
- Innate immune system aggravates severe COVID-19
- Metabolic response behind reduced cancer cell growth
- Increased cancer risk in children of mothers with thyroid disorders
- Disrupted immune cell navigation in lymph nodes of breast cancer patients
New publications from IGP
Anju, ; Chaturvedi, Shubhra; Chaudhary, Vishakha; Pant, Pradeep; Jha, Preeti; Kumaran, Senthil S.; Hussain, Firasat; Mishra, Anil Kumar
5-HT1A targeting PARCEST agent DO3AM-MPP with potential for receptor imaging: Synthesis, physico-chemical and MR studies
Hammarström, Klara; Imam, Israa; Mezheyeuski, Artur; Ekström, Joakim; Sjöblom, Tobias; Glimelius, Bengt
A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
Nylund, Patrick; Atienza Párraga, Alba; Haglöf, Jakob; De Bruyne, Elke; Menu, Eline; Garrido-Zabala, Berta; Ma, Anqi; Jin, Jian; Öberg, Fredrik; Vanderkerken, Karin; Kalushkova, Antonia; Jernberg-Wiklund, Helena
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma.